Oblimersen in Treating Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia
Clinical trial NCT00062244 · COMPLETED
Trial details
- NCT number
- NCT00062244
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-05-01
- Primary completion
- 2007-06-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.